Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study

@inproceedings{Korol2017IntravitrealAF,
  title={Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study},
  author={Andrii R Korol and Oleksandra Zborovska and Taras B Kustryn and Oleksandra Dorokhova and Nataliya V Pasyechnikova},
  booktitle={Clinical ophthalmology},
  year={2017}
}
PURPOSE The purpose of this study was to evaluate the potential benefits of intravitreal aflibercept injections for the treatment of choroidal neovascularization (CNV) secondary to chorioretinitis. METHODS In this uncontrolled, prospective cohort study, 15 eyes of 14 consecutive patients affected by CNV associated with ocular toxoplasmosis were treated with intravitreal aflibercept (2 mg) pro re nata and observed over a 12-month follow-up period. The primary outcome was the change in best… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES